Bristol Myers Squibb’s Journey: Adopting a Modern Data Infrastructure & Analytics Platform
Overview
The amount and diversity of data incorporated into clinical trials are growing dramatically. In this environment, life sciences companies must optimize data flow at scale. Clinical data ecosystems must facilitate the exchange of information within organizations, as well as with outsourced partners.
To address these challenges, in 2018 Bristol Myers Squibb embarked on building a new clinical data infrastructure and analytics solution built on eClinical Solutions’ elluminate Clinical Data Cloud platform. This initiative has helped streamline the clinical data lifecycle, reducing cycle times and time to insight.
This executive summary is based on the March 2023 webinar “Bristol-Myers Squibb’s Journey: Adopting A Modern Data Infrastructure & Analytics Platform”, where David Weigand and Jayabarathi Rajasekaran discussed lessons Bristol Myers Squibb (BMS) learned over the past four years adopting a new clinical data infrastructure and analytics platform. They also shared how BMS is taking their systems to the next level to improve clinical data efficiency.
What You Will Learn:
- How a modern centralized clinical data infrastructure and analytics platform improved and impacts BMS’s clinical data lifecycle
- Data flow optimization at scale for a multi-therapeutic area clinical data ecosystem that includes numerous outsourced partners
- Technology adoption and rollout best practices, lessons learned and strategies for successful execution
- Digital trial foundations and growth opportunities to maximize cycle time, regulatory compliance and time to insight